Financial Information
SEC Filings
AMF Regulated Information
| Document | Year | Terms |
|---|---|---|
11/20/2018 - 7:30 am | Press releases DBV Technologies Presents Data at ACAAI 2018 on Investigational Viaskin Peanut for the Treatment of Peanut-Allergic ChildrenDownload PDF (415 KB) | ||
11/16/2018 - 7:30 am | Press releases DBV Technologies Appoints Daniel Tassé as Chief Executive OfficerDownload PDF (451 KB) | ||
11/07/2018 - 6:30 pm | Outstanding shares and voting rights statements Monthly information regarding the total number of voting rights and total number of shares of the CompanyDownload PDF (88 KB) | ||
10/30/2018 - 7:30 am | Press releases | Quarterly financial information DBV Technologies Reports September 30, 2018 Cash PositionDownload PDF (376 KB) | ||
10/22/2018 - 7:30 am | Press releases DBV Technologies Announces Submission of Biologics License Application for Viaskin Peanut to the U.S. Food and Drug AdministrationDownload PDF (351 KB) |
Annual Reports & General Meetings
| Document | Year | Terms |
|---|---|---|
09/07/2018 - 7:30 am | Finance DBV Technologies Reports First Half 2018 Financial ResultsDownload PDF (517 KB) | ||
09/07/2018 - 7:30 am | Finance Half Year Financial Report 2018Download PDF (596 KB) | ||
07/27/2018 - 7:30 am | Finance DBV Technologies Reports June 30, 2018 Cash PositionDownload PDF (375 KB) | ||
06/26/2018 - 4:52 pm | General Assembly Annual General Meeting, June 22, 2018Vote results | ||
06/26/2018 - 4:51 pm | General Assembly Annual General Meeting, June 22, 2018Quorum |
